Asset Purchase Agreement between GRI Bio, Inc. and Aardvark Therapeutics, Inc.Asset Purchase Agreement • August 23rd, 2023 • GRI BIO, Inc. • Pharmaceutical preparations • Delaware
THIS ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of this 22nd day of August 2023 (“Effective Date”) between Aardvark Therapeutics, Inc., a company organized and existing under the laws of the State of Delaware, with its principal offices at 4747 Executive Drive, Suite 1020, San Diego, California 92121 US (“Aardvark”), and GRI Bio, Inc. (formerly, Vallon Pharmaceuticals, Inc.), a company organized and existing under the laws of Delaware, with its principal offices at 2223 Avenida De La Playa #208, La Jolla, CA 92037 (“GRI”).
